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ABSTRACT 
 
Although the role of vitamin C in common cold incidence had been studied extensively, the level of vitamin 
C intake has not been unequivocally shown to affect the incidence of colds. In the present study the six 
largest vitamin C supplementation (? 1 g/d) studies, including over 5000 episodes in all, have been analysed, 
and it is shown that common cold incidence is not reduced in the vitamin C-supplemented groups compared 
with the placebo groups (pooled rate ratio (RR) 0.99; 95 % CI 0.93, 1.04). Consequently these six major 
studies give no evidence that high-dose vitamin C supplementation decreases common cold incidence in 
ordinary people. Nevertheless, the analysis was continued with the hypothesis that vitamin C intake may 
affect common cold susceptibility in specific groups of people. It was assumed that the potential effect of 
supplementation might be most conspicuous in subjects with low dietary vitamin C intake. The average 
vitamin C intake has been rather low in the UK and plasma vitamin C concentrations are in general lower in 
males than in females. In four studies with British females vitamin C supplementation had no marked effect 
on common cold incidence (pooled RR 0.95; 95 % CI 0.86, 1.04). However, in four studies with British male 
schoolchildren and students a statistically highly significant reduction in common cold incidence was 
found in groups supplemented with vitamin C (pooled RR 0.70; 95 % CI 0.60, 0.81). Thus, these studies with 
British males indicate that vitamin C intake has physiological effects on susceptibility to common cold 
infections, although the effect seems quantitatively meaningful only in limited groups of people and is not 
very large. 
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INTRODUCTION 
 
Phagocytes and lymphocytes concentrate vitamin C at levels up to 100 times higher than in plasma (Evans et 
al. 1982; Bergsten et al. 1990; Washko et al. 1993) suggesting that this vitamin has a physiological role in 
these immune-system cells. Vitamin C has been reported to increase the proliferative responses of T-
lymphocytes in vitro (Manzella & Roberts, 1979; Oh & Nakano, 1988; Smit & Anderson, 1990) and in 
some studies with human subjects (Yonemoto, 1979; Anderson et al. 1980; Kennes et al. 1983). Furthermore, 
vitamin C has been reported to increase the induced production of interferon in cell culture (Schwerdt & 
Schwerdt, 1975; Siegel, 1975; Dahl & Degre, 1976) and in mice (Siegel, 1974; Geber et al. 1975). Thus 
there are experimental studies indicating that vitamin C may have effects on the immune system. However, it 
is not known to what extent these reported effects have physiological relevance, for example, whether vitamin 
C intake in particular circumstances affects the susceptibility of human beings to infections. 
The effects of vitamin C supplementation on the incidence of common cold episodes have been 
extensively studied. Placebo-controlled studies have consistently shown that high doses of the vitamin 
alleviate the symptoms of the common cold (Hemilä, 1992, 1994, 1996a; Hemilä & Herman, 1995). In contrast, 
the results of vitamin C supplementation on the incidence of colds have been ambiguous. Although in a meta-
analysis of four placebo-controlled studies Pauling (1971) found strong evidence that vitamin C 
supplementation decreases common cold incidence (P < 0.002), later studies have mostly found no 
substantial effect (Hemilä, 1992, 1994). Nevertheless, a significant reduction in the number of colds in the 
vitamin C-supplemented groups has been observed in some studies, suggesting that the issue deserves a 
detailed analysis. If vitamin C has physiologically important effects on the immune system, it is possible that 
these effects are quantitatively meaningful only in limited groups of people. It has been suggested that 
subjects under heavy acute physical stress is one of the groups in which vitamin C supplementation may 
decrease the incidence of the common cold (Hemilä, 1996b). Also, subjects with low dietary intake may 
form one of the groups in which the effects of supplementation are most apparent. The purpose of the present 
study was to see whether vitamin C supplementation has any consistent effect in subjects with a low dietary 
intake of the vitamin. 
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METHODS 
 
Selection of the studies 
The literature on vitamin C–common cold studies has been thoroughly surveyed by several authors (Briggs, 
1984; Kleijnen et al. 1989; Hemilä, 1994), and two exhaustive reference lists have been published (Briggs, 
1984; Kleijnen et al. 1989). The previous searches were extended by Medline and Scisearch database searches 
to identify vitamin C–common cold intervention studies published since 1988. Two groups of studies were 
selected for further analysis. 
First, placebo-controlled double-blind studies in which ? 1 g vitamin C/d was regularly administered and 
in which there were ? 200 common cold episodes in all were sought. Seven studies belonging to this group 
were identified (Table 1). The second study by Anderson et al. (1974) is not included in Table 1, since there 
is evidence of bias in the distribution of subjects in the eight study groups (Anderson et al. 1974; Hemilä & 
Herman, 1995). Nevertheless, the results of this latter study are not inconsistent with the results shown in 
Table 1. Anderson et al. (1972) corrected some parts of their data afterwards (Anderson et al. 1973). The 
results of the Karlowski et al. (1975) study were recently re-analysed (Hemilä, 1996a). In each of the six 
major studies included in Table 1 the subjects were randomly allocated to the study groups. 
Second, studies carried out in the UK were searched for. Eight studies that had analysed the effect 
of vitamin C supplementation on common cold incidence were identified (Tables 2 and 3). Walker et al. 
(1967) examined the effect of vitamin C on experimental colds initiated by inoculation with common cold 
viruses. In experimental common cold infections a large dose of virus is used to infect as many subjects as 
possible during a short test period. However, if vitamin C has only quite modest physiological effects these 
may be detectable only when small doses of viruses challenge people in their normal daily lives, and not when 
very large infecting doses are used. Therefore Walker’s study was not included in the analysis of the natural 
common cold infections (Tables 2 and 3). Carson et al. (1975) did not separate their subjects into men and 
women and so their study is not included in Table 2 or Table 3. 
Glazebrook & Thomson (1942) did not use a placebo but added the vitamin to the food of schoolboys, and 
the subjects were allocated to the study groups as seven divisions who occupied certain tables in the dining 
hall. All the other British studies were placebo-controlled. Four of the studies were double-blind and 
randomized (Carson et al. 1975; Elwood et al. 1976; Tyrrell et al. 1977; Baird et al. 1979). The method of 
allocation was not described by Charleston & Clegg (1972) and Clegg & Macdonald (1975); the latter study 
was double-blind but the former was not. The results of the Charleston & Clegg (1972) study were 
originally published without division by sex, but in a later publication the data were separated for males and 
females (Clegg, 1974). 
 
Statistical methods 
The one-tailed P values are used in the text in discussing the difference between the vitamin C and control 
groups since there is no theoretical or experimental reason to expect that vitamin C supplementation could 
increase the incidence of the common cold, and because the explicit question in the present analysis 
was whether vitamin C supplementation decreases the incidence or not. When the published results 
have made it possible, the P values have been recalculated using the ?2 test. 
In Tables 1 and 2 the common cold incidence rate (I) in the study groups was calculated from the 
published results (IC for the vitamin C group and IP for the placebo group). The number of person years and 
the incidence rate were calculated merely for the purpose of allowing comparison between the studies. The 
number of person years was not given in any study but was calculated from the duration of the study and the 
number of subjects, although in several cases the duration was not accurately described. Nevertheless, in Tables 
1 and 2 the durations of the studies were equal for their respective vitamin C and placebo groups, allowing 
calculation of the rate ratio RR (= IC/IP) directly from the numbers of subjects and episodes. 
In Table 3 the outcome measure is dichotomous; the subjects are divided into two groups on the basis 
of either having or not having recurrent common cold infections during the study. The proportion of subjects 
falling sick during the study (p) was calculated from the published results (pC for the vitamin C group and pP 
for the placebo group). In Table 3 the relative risk was calculated as the ratio of the proportions (RR = 
pC/pP). 
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In certain studies the total number of episodes was not given, but rather the mean number of episodes 
per person. In these cases the total number of episodes was calculated as the product of the number of 
subjects and the mean number of episodes. Baird et al. (1979) gave the number of subjects who had had 0, 1 
or ? 2 long colds (3–5 d) and 0, 1, 2 or ? 3 short colds (1–2 d), but the total or average number of episodes was 
not given. The total number of episodes was calculated from the data on the approximation that ? 2 and ? 3 
indicate 2 and 3 colds respectively, so that there are a few episodes missing. 
The 95 % confidence interval (95 % CI) for the RR found in each study was calculated with the normal 
distribution approximation of the Poisson distribution in Tables 1 and 2, and with the normal distribution 
approximation of the binomial distribution in Table 3. With the normal distribution approximation the 
variances needed for the 95 % CI were calculated in Tables 1 and 2 as var(log(RR)) = (1/EC +1/EP) (E 
being the number of episodes), and in Table 3 as var(log(RR)) = [(1 – pC)/SC + (1 – pP)/SP] (S being the 
number of subjects with ? 2 episodes). 
In Tables 1–3 the pooled RR and the 95 % CI were derived by averaging the individual logarithm values 
log(RR) using the inverses of variances var(log(RR)) as the weights with the following formulas (Rothman, 
1986): 
 
log(RRpool) = ?log(RRi) ?var(log(RRi))  ?  ?1 ?var(log(RRi)) 
 
var(log(RRpool)) = 1  ?  ?1 ?var(log(RRi)) 
 
95 % CI limits: RRUp,Low = RRpool × exp{±1.96?var(log(RRpool))} 
 
 
In Table 2 Elwood et al.’s (1976) results are divided into 'simple' and 'chest' colds in order to visualize the 
possible difference between the two case definitions. Also, a single result from Elwood's study can be used in 
the pooling procedure (RR derived from the sum of the two subcategories), but this leads to identical pooled 
RR and 95 % CI values (results not shown). The one-tailed P value corresponding to the pooled estimate 
(Tables 2 and 3) was derived from the standard normal deviate z = log(RRPool)/ ? var(log(RRPool)). 
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RESULTS 
 
Pooling the results of six major studies with high vitamin C doses 
If regular high-dose vitamin C supplementation markedly decreases the incidence of the common cold as 
Pauling (1970, 1971) claimed, the most convincing evidence should be seen in studies in which a large dose 
of the vitamin is used and large numbers of common cold episodes are recorded. A study employing a low 
vitamin C dose could fail to show any effect simply because the dose was too small, and therefore ? 1 g vitamin 
C/d was used as a criterion in selecting the major studies. As a second criterion it was required that at least 
200 common cold episodes be observed in the study. Smaller studies were left out since small studies with 
negative results may remain unpublished, while there is much less risk of publication bias in the case of 
large-scale studies. Furthermore, the total number of episodes in the smaller studies with ? 1 g vitamin C/d 
is approximately 1000 (Hemilä, 1992), so that even their combined weight is small compared with the 
weight of the six largest studies containing over 5000 common cold episodes in all (Table 1). None of these six 
major studies found a statistically significant decrease in common cold incidence. Furthermore, pooling the 
six studies did not reveal any meaningful overall difference between the vitamin and the placebo groups 
(Table 1). Thus the six major studies give no support to the suggestion that regular high-dose vitamin C 
supplementation markedly decreases the incidence of the common cold across a range of populations in 
Western countries. 
 
Table 1. Vitamin C and common cold incidence: large-scale placebo-controlled studies 
 
 
Ref. 
 
Country 
and 
subjects 
 
Dose 
of vit C 
(g/d) 
 
Duration 
of study 
(months) 
Vitamin C group Placebo group  
RR 
(Ic / Ip) 
 
95% CI 
No. of 
subjects 
Person-
years 
No. of 
episodes 
(Ec) 
Incidence 
rate (Ic) 
(1/year) 
No. of 
subjects 
Person-
years 
No. of 
episodes 
(Ep) 
Incidence 
rate (Ip) 
(1/year) 
Anderson et al. 
(1972, 1973) 
Canada, 
adults 
1 3 407 102 561 5.5 411 103 609 5.9 0.93 0.83, 1.04 
Elwood et al. 
(1976) 
UK, 
women 
1 3 339 93 627 6.7 349 96 690 7.2 0.93 0.84, 1.04 
Karlowski et 
al. (1975) 
USA, 
adults 
3 9 101 76 128 1.7 89 67 121 1.8 0.93 0.73, 1.20 
Pitt & Costrini 
(1979) 
USA, 
military 
recruits 
2 2 331 51 600 11.8 343 53 619 11.8 1.00 0.90, 1.12 
Briggs (1984) Australia, 
adults 
1 ??6 265 103 125 1.2 263* 102 121 1.2 1.03 0.80, 1.32 
Ludvigsson et 
al. (1977) 
Sweden, 
school-
children 
1 3 304 76 657 8.6 311* 78 622 8.0 1.08 0.97, 1.21 
   Totals: 1747  2698  1766  2782 RRpool: 0.99 0.93, 1.04 
 
* Ludvigsson et al. (1977) and Briggs (1984) administered 10 mg/day and 50 mg/day of vitamin C respectively to the placebo group 
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Still, it is noteworthy that Anderson et al. (1972) found that 18 % of the control group but 26 % of the 
vitamin group remained free of illness during the study period (P = 0.006). Furthermore, if vitamin C does 
have a small physiological effect it may depend on the type of infection; either on the aetiological agent or on 
the tissues affected. It is therefore noteworthy that Elwood et al. (1976) found a statistically significant 
decrease (–18 %; see Table 2) in the incidence of ‘chest colds’ (cough or other chest symptoms) in the vitamin 
C group, but no effect (+1 %) on the incidence of ‘simple colds’ (runny nose or sneezing). Similarly, 
Anderson et al. (1972, 1973) observed a moderate decrease in the incidence of ‘throat colds’ (–21 %; 0.34 and 
0.43 per subject), but no effect (–2 %) on the incidence of ‘nose colds’. The latter authors did not comment on 
the possible statistical significance of the difference (Anderson et al. 1973), but assuming that there was at 
most one ‘throat cold’ episode per subject the difference is significant in the ?2 test (P < 0.01). In both of 
these two studies the number of ‘nose colds’ was about two-thirds of all colds. Accordingly, these two 
major studies suggest that vitamin C supplementation may have a slight effect on the incidence of certain 
types of common cold infections. 
 
Dietary vitamin C intake in the six major studies 
If vitamin C intake affects susceptibility to common cold infections, the effect of supplementation may be 
most pronounced in subjects with an initially low vitamin C intake. A large dietary intake probably causes 
saturation of any potential effects of vitamin C on the immune system, whereas subjects with low levels of 
intake could suffer from some functional deficiencies in the immune system. In the latter case supplements 
could produce benefits from a correction of marginal deficiency, while in the former case supplements 
would produce no effect since the saturation levels have already been reached. Although the clinical signs of 
scurvy start to appear when plasma vitamin C level decreases below 10 ?mol/l, there are large individual 
differences in the appearance of the symptoms (Hodges et al. 1971). If, then, marginal vitamin C deficiency 
increases susceptibility to common cold infections, the effect could be observed in studies in which vitamin C 
intakes and plasma concentrations in the control subjects are rather close to the levels producing scurvy. 
Regarding the role of dietary intake in the six major studies, Briggs (1984), Ludvigsson et al. (1977) and 
Pitt & Costrini (1979) measured plasma vitamin C concentrations, fairly high mean levels being found in the 
control groups: 62, 49, and 52 ?mol/1 respectively. Only rather small increases in plasma vitamin C levels 
were found in the vitamin-supplemented groups compared with the placebo groups: +18 %, +24 %, and 
+49 % respectively. Furthermore, Briggs (1984) gave 50 mg vitamin C/d to the placebo subjects to avoid the 
possibility that any observed effect might result from the alleviation of a marginal deficiency. 
Consequently, these three studies are not critical as regards the question of whether low vitamin C intake is 
associated with an increased susceptibility to common cold infections. 
In the study by Karlowski et al. (1975), neither vitamin C intake nor plasma concentration was 
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estimated. They used a sample of employees of the National Institutes of Health (Bethesda, MD, USA) as 
subjects, and it seems likely that such subjects have a much healthier diet (e.g. more fruits containing 
vitamin C) than the population at large, so that this study may not be pertinent to the question of whether low 
vitamin C intake is associated with an increased number of cold episodes either. 
Consistent with the possibility that dietary vitamin C intake modifies the effects of supplementation, 
Anderson et al. (1972) found that regular vitamin C supplementation (l–4 g/d) decreased the total number of 
sickness days by 48 % in subjects who drank less than 0.12 litres (4 oz) of fruit juices daily, but only by 22 
% in subjects who drank more. The subgroup difference shows the importance of taking into account the 
initial dietary intake in considering the effects of supplementation. Fruit juices provide about half of all 
vitamin C intake (Block & Sorenson, 1987), and thus the amount of juice provides a reasonable estimate of 
total vitamin C intake. 
Thus, five of the major studies are not incompatible with the hypothesis that low vitamin C intake 
may be associated with an increased susceptibility to common cold infections. The analysis was therefore 
continued on the hypothesis that many reported decreases in cold incidence with vitamin C 
supplementation are explainable by physiological effects which are, however, more properly interpreted 
as a correction of marginal deficiency than by the effects of high doses per se. 
 
Low level of dietary vitamin C intake: the British studies 
Neither dietary vitamin C intake nor plasma vitamin C concentration has been examined in most of the 
common cold intervention studies and therefore a subgroup of studies cannot be selected with a well-defined 
criterion for poor initial vitamin status among the study subjects. A surrogate criterion was therefore used to 
select a strictly defined group of studies with subjects having relatively low vitamin C intake; namely studies 
carried out in the UK (Tables 2 and 3). 
 Several studies over a long period have reported fairly low vitamin C intake in groups of subjects in 
the UK: 30–60 mg/d (Allen et al. 1968; Milne et al. 1971; Lonergan et al. 1975; Black et al. 1976; Smithells 
et al. 1977; Bates et al. 1979; Darke et al. 1980; Crombie et al. 1990; Bolton-Smith et al. 1993). By 
comparison, the mean vitamin C intake in the USA has been estimated to be 90–120 mg/d (Block & 
Sorenson, 1987). Furthermore, in a recent comparison of middle-aged men in three European countries 
(Riemersma et al. 1990) the lowest plasma vitamin C concentrations were observed in the UK (median 18 
?mol/l), whereas the levels were twice as high in Italy (median 38 ?mol/l), and substantially higher in Finland 
as well (medians 28 and 33 ?mol/1 in two regions). Finally, the recommendation for vitamin C intake in the 
UK (30 mg/d for adults) has been the lowest in Western Europe (Trichopoulou & Vassilakou, 1990) being half 
of the recommended dietary allowance in the USA (60 mg/d; National Research Council, 1989). However, the 
UK recommendation was recently increased to 40 mg/d (Department of Health, 1991). 
Dietary vitamin C intake was crudely estimated in two common cold studies carried out in the UK. 
9 
 
Baird et al. (1979) estimated that their subjects received 50 mg vitamin C/d and Glazebrook & Thomson 
(1942) estimated that their subjects received 10–15 mg/d. Clegg & Macdonald (1975) noted that the 
average British diet contains approximately 44 mg vitamin C/d, although they did not estimate the intake of 
their own subjects. It is assumed in the present study that the dietary intake has also been low in the other 
common cold studies carried out in the UK although precise estimations have not been made by the authors of 
the reports. 
 
Pooling the results of the British studies 
So far seven British studies have examined the effect of vitamin C supplementation on the incidence of natural 
common cold infections. In Table 2 the results for males and females are separated. Usually plasma and 
leucocyte vitamin C concentrations are lower in males than in females (Milne et al. 1971; Burr et al. 1974; 
Bates et al. 1979; Garry et al. 1982; Itoh et al. 1989; Oreopoulos et al. 1993), although it is not clear to 
what extent this is due to dietary and physiological differences between the sexes. Consequently a greater 
and more consistent effect on males should be expected from supplementation, assuming that low vitamin C 
levels increase susceptibility to colds. Four UK studies for which there are data for males found a lower 
incidence of colds in the vitamin C-supplemented group (Table 2). Pooling the four studies yields a 
combined rate ratio (RR) of 0.70 for common cold infections in the vitamin C groups. It is highly unlikely that 
the reported differences between the vitamin C and control groups in males were caused purely by chance. 
The study by Glazebrook & Thomson (1942) is the largest of the male studies in Table 2 and thus has 
great weight in the pooling procedure. However, there are numerous shortcomings in the study. For example, 
a placebo was not used, the vitamin being added to the food of the subjects, but much of the supplementary 
vitamin was degraded during the preparation of food. The study is also poorly described: for example, the 
duration of the study, the total number of episodes, and the exact amount of vitamin C added to food during 
the observation period are not described. If the Glazebrook & Thomson (1942) study is excluded from the 
analysis because of the technical shortcomings, the RR estimate for males becomes 0.64 (95% CI 0.53, 0.77). 
Thus, the exclusion of the technically most deficient study leads to a somewhat increased difference between 
the pooled vitamin C and control groups. 
The effect of vitamin C supplementation in females has been inconsistent, the pooled estimate 
suggesting that there is no marked overall effect (Table 2). Nevertheless, Elwood et al. (1976) found a 
statistically significant decrease in the incidence of ‘chest colds’. 
In addition to the studies in Table 2, Carson et al. (1975) carried out two 11-week studies in the UK on 
the effect of vitamin C (1 g/d) on the incidence of colds with 244 adults of both sexes. No benefit was 
observed in either study. However, men and women were not separated in Carson's studies, preventing their 
inclusion in Table 2. 
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Table 2. Vitamin C and common cold incidence: British studies* 
 
 
Ref. 
 
Subjects 
 
Dose of 
vit C 
(g/d) 
 
Duration 
of study 
(weeks) 
Vitamin C group Placebo group  
RR 
(Ic / Ip) 
 
95% CI 
No. of 
subjects 
Person-
years 
No. of 
episodes 
(Ec) 
Incidence 
rate (Ic) 
(1/year) 
No. of 
subjects 
Person-
years 
No. of 
episodes 
(Ep) 
Incidence 
rate (Ip) 
(1/year) 
Males              
Charleston 
& Clegg 
(1972) 
Students 
and adults 
1 15 24 6.9 14 2.0 30 8.7 54 6.2 0.32 0.18, 0.58 
Baird et al. 
(1979) 
Students 0.08 10 133 26 184 7.0 61 12 135 11.2 0.63 0.50, 0.78 
Glazebrook 
& Thomson 
(1942) 
Schoolboys 0.05 
-0.3 
? † 335 ? 72 ‡ ? 1100§ ? 286 ‡ ? 0.83 0.64, 1.07 
Clegg & 
Macdonald 
(1975) 
Students 1 14 89? 24 75 3.1 47 13 43 3.4 0.92 0.63, 1.34 
   Totals: 581  345  1238  518 RRpool: 0.70 0.60, 0.81 
           P = 0.000001 
Females              
Charleston 
& Clegg 
(1972) 
Students 
and adults 
1 15 23 6.6 30 4.5 13 3.8 26 6.9 0.65 0.39, 1.10 
Clegg & 
Macdonald 
(1975) 
Students 1 14 52? 14 44 3.1 23 6.2 30 4.8 0.65 0.41, 1.03 
Elwood et 
al. (1976) 
Adults 1 14 339 93 211¶ 2.3 349 96 266¶ 2.8 0.82 0.68, 0.98 
416** 4.5 424** 4.4 1.01 0.88, 1.16 
Baird et al. 
(1979) 
Students 0.08 10 105 21 199 9.6 51 10 78 7.7 1.24 0.95, 1.61 
   Totals: 519  900  436  824 RRpool: 0.95 0.86, 1.04 
 
* Two studies by Carson et al. (1975) are not included owing to lack of sufficient data. 
† The duration of the study was not given, but it was 'during the winter months.' 
‡ The number of colds was not given, the value is the number of subjects that caught colds, but it is not known whether some of 
them had more than one cold. 
§ Placebo was not used, but vitamin C was administered in food. 
? L-Ascorbic and D-isoascorbic groups are combined. 
¶ Number of 'chest colds.' 
** Number of 'simple colds' (nasal colds). 
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The British studies analysed in Table 2 used regular supplementation, i.e. vitamin C was administered 
each day during the study period. In contrast, Tyrrell et al. (1977) carried out a study in which they 
administered vitamin C (4 g/d) for 2.5 d during the first cold episode only. They found a 40 % decrease (P 
= 0.02) in the number of men with recurrent common cold infections. The effect of vitamin C on 
recurrent common cold infections in the studies with British males yielded a combined RR of 0.54 for 
subjects with recurrent infections in vitamin C-supplemented groups during the study period of 10–16 
weeks (Table 3). In line with the small and inconsistent differences in females in the other studies (Table 2), 
Tyrrell et al. (1977) found no decrease in recurrent infections in women administered vitamin C. 
 
 
Table 3. Vitamin C and recurrent common cold infections in British males* 
 
 
Ref. 
 
Subjects 
 
Duration of 
study 
(weeks) 
Vitamin C group Placebo group  
RR 
(pc / 
pp) 
 
95% CI 
No. of 
subjects 
No. with 
?2 episodes 
(Sc) 
Proportion 
sick (pc) 
No. of 
subjects 
No. with 
?2 episodes 
(Sp) 
Proportion 
sick (pp) 
Charleston 
& Clegg 
(1972) 
Students 
and adults 
15 24 14 0.08 30 17 0.57 0.15 0.04, 0.57 
Baird et al. 
(1979) 
Students 10 133 21† 0.16 61 23† 0.38 0.42 0.25, 0.70 
Tyrrell et 
al. (1977) 
Adults 16 351 23 0.07 392 43 0.11 0.60 0.37, 0.97 
Clegg & 
Macdonald 
(1975) 
Students 14 89‡ 18 0.20 47 9 0.19 1.06 0.51, 2.17 
  Totals: 597 64  530 92 RRpool: 0.54 0.40, 0.74 
        P = 0.00005 
 
* Two studies by Carson et al. (1975) are not included owing to lack of sufficient data. 
† Long episodes (3–5 d). 
‡ L-Ascorbic and D-isoascorbic groups are combined. 
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DISCUSSION 
 
A large number of studies have been carried out to determine whether vitamin C supplementation decreases 
the incidence of common cold infections. In most studies the main incentive was to test Pauling’s (1970, 
1971) claim that large doses of vitamin C may prevent and alleviate colds. From the studies published so far 
it is clear that high-dose vitamin C supplementation has no marked effect on the number of common cold 
episodes in ordinary people (Table 1; Hemilä, 1992, 1994). Nevertheless, it is possible that vitamin C 
supplementation affects the susceptibility to colds in certain restricted groups of people. Subjects with low 
dietary intake of the vitamin would probably show the most conspicuous effects of supplementation assuming 
that the level of vitamin C intake is important. 
The notion that a low level of vitamin C intake may increase susceptibility to infections is an old 
one (Robertson, 1934; Perla & Marmorston, 1937a,b; Bourne, 1949). For example, early this century Höjer 
(1924) found that guinea pigs fed on a diet deficient in vitamin C readily contracted infections, mainly of the 
upper respiratory tract, but also pneumonia. Hess (1932) suggested that even in the absence of overt 
symptoms vitamin C deficiency lowers resistance to various infections. 
Consequently, it is possible that in studies that have shown a reduction in common cold incidence in a study 
group supplemented with vitamin C the effect was not due to the high dosage per se, but rather to the 
correction of a marginal deficiency in the study subjects. This interpretation is not incompatible with the 
negative results of the six major studies (Table 1), which mostly used subjects with a fairly high dietary 
vitamin C intake. Nevertheless, two of the major studies suggested that vitamin C supplementation may have a 
slight effect on common cold incidence (Anderson et al. 1973; Elwood et al. 1976). 
In the present paper the common cold studies carried out in the UK were selected for analysis, since low 
levels of vitamin C intake have been observed in a number of UK studies indicating that average intake 
there has been fairly low. Pooling the results of four studies involving British males yielded strong evidence 
that vitamin C intake affects susceptibility to common cold infections (Table 2). A fifth UK study similarly 
found a statistically significant decrease in the incidence of recurrent colds in men supplemented with vitamin 
C (Table 3; Tyrrell et al. 1977). The studies by Baird et al. (1979) and Tyrrell et al. (1977) were randomized 
double-blind studies and therefore biases in the study groups do not provide simple explanations for the 
observed differences in these two studies in particular. 
Pooling the studies involving British males yielded estimates of a 30 % decrease in the number of 
common cold episodes (Table 2) and a 46 % decrease in the number of males with recurrent infections (Table 
3) with vitamin C supplementation. Nevertheless, these estimates should be interpreted as crude 
approximations. The primary purpose of the present study was to see whether vitamin C differs from 
placebo when common cold incidence is used as an outcome. If vitamin C intake does have an effect on the 
incidence there is obviously no single estimate for the effect size that is generally applicable. For example, 
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with an increase in the dietary vitamin C intake the effect of supplementation evidently decreases towards nil, 
which may be the case in the studies in Table 1. It is also possible that there are other factors modifying the 
quantitative effects of vitamin C intake in a group of subjects. A considerable difference between the sexes 
was found in the UK studies (Table 2); also it is noteworthy that four studies of males showing a substantial 
effect with vitamin C supplementation used students and schoolchildren as subjects (Table 2). Carson et al. 
(1975) used adult men and women as subjects in two studies which showed no effect of supplementation, 
suggesting that the age of subjects could modify the role of vitamin C intake in susceptibility to the 
common cold. Tyrrell et al. (1977) also used adult men but still found a significant decrease in recurrent 
colds (Table 3). Neither of the latter two studies with adults described the mean age or the age range of their 
subjects, or other characteristics of the subjects, thereby hampering any more detailed comparisons. It 
appears likely that the characteristics of subjects and experimental conditions modify the role of vitamin C 
intake, but the limited data available do not allow any definite conclusions to be drawn. Thus, the studies with 
British males indicate that vitamin C intake has a physiological effect on the susceptibility to colds in certain 
people, but further studies are required for a more accurate estimate of the practical significance of this effect. 
Baird et al. (1979) used only 80 mg supplemental vitamin C/d and found a substantial decrease in 
common cold incidence in men. Baird et al. (1979) estimated that the dietary intake was 50 mg/d and, thus, 
the total intake in the vitamin C-supplemented group was approximately 130 mg/d. Consequently this study 
gives the most direct support to the interpretation that it is the correction of marginal deficiency that is the 
reason for the observed benefit in the studies shown in Table 2. 
Finally, the potential effect of vitamin C intake on susceptibility to the common cold also seems 
important as regards nutritional recommendations. It is noteworthy that in studies carried out in the UK a 
considerable decrease in common cold infections with vitamin C supplementation was found, while the 
recommended level of vitamin C intake in the UK has been the lowest in Western Europe (Trichopoulou & 
Vassilakou, 1990). The goal of the nutritional recommendations is to prevent overt scurvy in healthy people and 
for that purpose 10 mg vitamin C/d is sufficient (National Research Council, 1989; Department of Health, 
1991). Nevertheless, the nutritional recommendations of 30–60 mg/d are not based either on 
epidemiological studies or on clinical trials, suggesting that such doses are better than 10 mg/d as regards any 
health status outcome. The purpose is merely to provide passive ‘reserves’ against scurvy (Hemilä, 1984, 
1986, 1991; National Research Council, 1989; Department of Health, 1991). Accordingly, it is conceivable that 
the best doses in the long term are higher than those officially recommended (Pauling, 1974; Hughes, 1981; 
Hemilä, 1986; Levine & Morita, 1985; Ginter, 1989; Reynolds, 1994). The studies with British males 
discussed in the present paper suggest that there are dose-dependent effects of vitamin C intake on health 
outcomes even in the absence of scurvy, and therefore the absence of overt scurvy should not be used as the 
sole criterion in considering the adequacy of vitamin C intake for healthy people. 
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